Advances in Imaging and Biomarkers for Early Heart Failure Detection

Advances in imaging—especially speckle tracking echocardiography—and biomarkers like natriuretic peptides and hs-troponins are improving detection of Stage B heart failure, a subclinical phase with structural cardiac abnormalities. AI may boost precision.

• Transthoracic echocardiography with speckle tracking is the cornerstone for detecting subclinical myocardial remodeling.
• Biomarkers (natriuretic peptides, high-sensitivity cardiac troponins) aid in risk stratification and detection.
• Cardiac MRI, CT, nuclear imaging, and chest X-ray serve adjunctive roles; AI shows promise for enhancing early detection.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.